Peptron, Inc.

ISIN KR7087010005

 | 

WKN A1406E

Market cap (in EUR)
4.115 m
Country
Zuid-Korea
Sector
Gezondheidszorg
Dividend yield
0,00%
 

Overview

Description

Peptron, Inc. houdt zich bezig met de ontwikkeling van geneesmiddelen op basis van peptiden en nieuwe geneesmiddelen. De producten omvatten geneesmiddelen voor prostaatkanker, hyperpitarisme, diabetes, degeneratieve neuronale aandoeningen en obesitas, peptidematerialen en cosmetica. Het bedrijf werd opgericht op 21 november 1997 en heeft zijn hoofdkantoor in Daejeon, Zuid-Korea.
Show more Show less
Gezondheidszorg Gezondheidszorg Diensten Diversen Gezondheidszorg Zuid-Korea

Financials

Key metrics

Market capitalisation, EUR 4.115 m
EPS, EUR -0,37
P/B ratio 50,4
P/E ratio -
Dividend yield 0,00%

Income statement (2025)

Revenue, EUR 4 m
Net income, EUR -9 m
Profit margin -245,33%

What ETF is Peptron, Inc. in?

There are 4 ETFs which contain Peptron, Inc.. All of these ETFs are listed in the table below. The ETF with the largest weighting of Peptron, Inc. is the iShares MSCI Emerging Markets Small Cap UCITS ETF.
ETF Weight Investment focus Fund size (in m EUR)
iShares MSCI Emerging Markets Small Cap UCITS ETF 0,26%
Equity
Emerging Markets
Small Cap
290
Vanguard ESG Developed Asia Pacific All Cap UCITS ETF (USD) Distributing 0,04%
Equity
Asia Pacific
Social/Environmental
36
Vanguard ESG Global All Cap UCITS ETF (USD) Distributing 0,01%
Equity
World
Social/Environmental
465
iShares MSCI EM IMI Screened UCITS ETF USD (Dist) 0,04%
Equity
Emerging Markets
Social/Environmental
1,166
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.